Fact CheckerSign in

NCT06190652Completed

Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.

Real-world Experience of Immunotherapy Plus Chemotherapy as First-line Treatment With or Without Radiotherapy for Patients With Advanced Oesophageal Squamous Cell Carcinoma in China

Source: ClinicalTrials.gov · Last updated 5 Feb 2024

Brief summary (registry, in English)

This study is a multi-center, non-interventional study. Clinicopathologic, treatment , outcome and efficacy data will be collected from medical records in metastatic esophageal squamous cell carcinoma (ESCC) patients.

Status (registry)
Completed
Study type
Observational
Enrollment
728 (actual)
First submitted
19 Dec 2023
Start date
13 Oct 2018
Primary completion date
4 Dec 2023
Lead sponsor
Tianjin Medical University Cancer Institute and Hospital
NCT number
NCT06190652

What you commit to

  • Study type: Observational
  • Participants enrolled: 728
  • From 13 Oct 2018 to the primary completion date, 4 Dec 2023
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those who have a history of autoimmune disease or have been treated with immunosuppressants within the last 3 months.
  • Those who have received organ transplant surgery.

Other illness

  • Surgery for esophageal cancer;
  • Risk of gastrointestinal bleeding, oesophageal fistula or oesophageal perforation
  • Patients with a previous history of malignant tumor (skin basal cell carcinoma and cervical carcinoma in situ) survived tumor-free for 3 years after treatment.
    • Except for the above).
  • There are other serious diseases, such as myocardial infarction, cerebral infarction or severe cardiopulmonary insufficiency within 6 months

Other

  • Esophageal fistulae due to infiltration of the primary tumour.

Who the study is looking for

  • Pathologically diagnosed as esophageal squamous cell carcinoma;
  • The clinical stage is IVb stage, that is, non-regional lymph node metastasis and distant organ metastasis (AJCC8th) of esophageal carcinoma.
  • Patients had received no previous systemic therapy
  • Patients who had received at least one cycle of first-line chemotherapy combined with immunotherapy, received or did not receive radiotherapy;
  • Complete medical records;
  • ECOG0-2;

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hunan Cancer Hospital
Coordinator of this site? Confirm its status
ChangshaChinaUnknown status
Sichuan Cancer Hospital
Coordinator of this site? Confirm its status
ChengduChinaUnknown status
Shanxi Cancer hospital
Coordinator of this site? Confirm its status
TaiyuanChinaUnknown status
Tianjin Cancer Hospital
Coordinator of this site? Confirm its status
TianjinChinaUnknown status
Henan Cancer Hospital
Coordinator of this site? Confirm its status
ZhengzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.